Intrinsiqq

Dongwha Pharm Co., Ltd. (000020.XKRX) Dividend Analysis

Does Dongwha Pharm Co. (000020.XKRX) pay a dividend?

Yes. Dongwha Pharm Co. (000020.XKRX) pays a dividend: KRW 65.00 per share over the last twelve months, a dividend yield of 1.18% at the latest close.

Its dividend per share has shrunk at 18.4% a year over the last 5 years. The payout takes about 12.3% of earnings.

Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.

Dividend per share by fiscal year
Fiscal yearPer shareChange
2025KRW 65.00-63.9%
2024KRW 180.000.0%
2023KRW 180.000.0%
2022KRW 180.000.0%
2021KRW 180.000.0%
2020KRW 180.00+50.0%
2019KRW 120.000.0%
2018KRW 120.00-20.0%
2017KRW 150.00+36.4%
2016KRW 110.00+37.5%

Newest 10 of 16 fiscal years; the chart below has the full series. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.

000020.XKRX
Dividend31
Dividend under pressure

FCF does not fully cover the dividend, sustainability is a concern, no sustained growth pattern yet.

Based on TTM and annual data · Not a buy/sell signal

Score Breakdown

50

Safety

40% of composite

Earnings Payout100
12.3%Well-covered
FCF Coverage0
-2.5xNot covered
0

Growth

35% of composite

Dividend Streak0
0YNo sustained streak
Growth Rate0
-18.4%Declining
45

Income

25% of composite

Cash Yield (TTM)45
1.18%Below average

Composite = Safety (50) × 0.40 + Growth (0) × 0.35 + Income (45) × 0.25 = 31

Dividend Yield

1.18%

Per Share (TTM)

KRW 65.00

Payout Ratio

12.3%

5Y CAGR

-18.4%

Dividend Safety

Earnings Payout

12.3%

FCF Payout

—

FCF Coverage

-2.5x

Dividend Growth

Per Share (TTM)

KRW 65.00

Growth Streak

—

5Y CAGR

-18.4%

Dividend Income

Annual DPS (TTM)

KRW 65.00

Annual Income / KRW 10K

KRW 118

Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.

Yield History

Dongwha Pharm Co. (000020.XKRX) dividend: yield, safety and growth

Frequently asked

Does Dongwha Pharm Co. (000020.XKRX) pay a dividend, and how much?+

Yes, Dongwha Pharm Co. pays a regular dividend of about KRW 65.00 per share per year (a yield of roughly 1.2%). That is a payout ratio of about 12.3% of earnings, so it is not currently covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.

Is Dongwha Pharm Co.'s dividend safe?+

Dongwha Pharm Co.'s dividend looks not currently covered by free cash flow, with free cash flow covering the payout about -2.5 times over. Intrinsiqq scores its dividend safety at 50 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.

Has Dongwha Pharm Co. grown its dividend?+

Dongwha Pharm Co.'s dividend history is mixed. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.

What is Dongwha Pharm Co.'s dividend payout ratio?+

Dongwha Pharm Co. pays out about 12.3% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is not currently covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.

More on 000020.XKRX: Overview · Quality scorecard · DCF valuation · Financials

Related stocks: Drug Manufacturers - Specialty & Generic

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.